Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: May 19, 2023
Abstract
Background
:
Drug
addiction
can
seriously
damage
human
physical
and
mental
health,
while
detoxification
is
a
long
difficult
process.
Although
studies
have
reported
changes
in
the
oral
microbiome
of
methamphetamine
(METH)
addicts,
role
plays
this
process
still
unknown.
This
study
aims
to
explore
function
based
on
analysis
variations
metabolome
METH
addicts.
Results
We
performed
16S
rRNA
sequencing
saliva
samples
collected
from
278
addicts
105
healthy
controls
(CTL)
undergoing
at
center
Shandong,
China.
In
addition,
untargeted
metabolomic
profiling
was
conducted
220
(170
50
CTL)
identify
biomarkers
build
classifiers
for
both
microbiota
metabolites.
Compared
CTL
group,
alpha
diversity
reduced
group
with
significant
differences
metabolic
pathways,
including
enhanced
tryptophan
metabolism,
lysine
biosynthesis,
purine
steroid
biosynthesis.
Conversely,
pathways
porphyrin
glutathione
pentose
phosphate
were
significantly
reduced.
It
speculated
that
four
key
microbial
taxa,
i.e.,
Peptostreptococcus
,
Gemella
Campylobacter
Aggregatibacter
could
be
involved
toxicity
mechanisms
by
affecting
above
pathways.
prediction
models
more
effective
than
metabolite-based
identifying
addiction.
Conclusions:
Our
identified
potential
functional
connections
between
profile
providing
novel
insights
into
exploring
toxic
underlying
Open Life Sciences,
Journal Year:
2024,
Volume and Issue:
19(1)
Published: Jan. 1, 2024
Abstract
Low-carbohydrate
diets
(LCDs)
are
frequently
recommended
for
alleviating
obesity,
and
the
gut
microbiota
plays
key
roles
in
energy
metabolism
weight
loss.
However,
there
is
limited
in-human
research
on
how
LCD
changes
microbiota.
In
this
before–after
study,
43
participants
were
assigned
to
intervention
4
weeks.
The
main
objective
was
investigate
specific
that
occur
participants’
microbiome
response
LCD.
Changes
analyzed
using
16s
rRNA
sequencing.
Body
composition
measured
InBody
770.
Remarkably,
35
(79.07%)
lost
more
than
5%
of
their
body
weight;
levels
BMI,
fat,
total
cholesterol
significantly
decreased,
indicating
effectiveness
intervention.
richness
increased
after
By
taking
intersection
ANOVA
linear
discriminant
analysis
effect
size
(LEfSe)
results,
we
identified
three
phyla,
classes,
four
orders,
five
families,
six
genera
differentially
enriched
between
baseline
week-4
time
points.
Among
relative
abundances
Firmicutes
Actinobacteriota
decreased
significantly,
while
Bacteroidetes
significantly.
At
genus
level,
Ruminococcus
,
Agathobacter
Streptococcus
Bifidobacterium
showed
a
significant
reduction
abundances,
whereas
Parabacteroides
Bacteroides
steadily.
Our
results
demonstrate
can
effectively
alleviate
obesity
modify
certain
taxa
microbiota,
providing
potential
insights
personalized
dietary
interventions
against
obesity.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
178, P. 117198 - 117198
Published: July 26, 2024
The
prevalence
of
obesity
is
increasingly
widespread,
resembling
a
global
epidemic.
Lifestyle
changes,
such
as
consumption
high-energy-dense
diets
and
physical
inactivity,
are
major
contributors
to
obesity.
Common
features
this
metabolic
pathology
involve
an
imbalance
in
lipid
glucose
homeostasis
including
dyslipidemia,
insulin
resistance
adipose
tissue
dysfunction.
Moreover,
the
importance
gut
microbiota
development
susceptibility
has
recently
been
highlighted.
In
recent
years,
new
strategies
based
on
use
functional
foods,
particular
bioactive
peptides,
have
proposed
counteract
outcomes.
context,
present
study
examines
effects
lupin
protein
hydrolysate
(LPH)
obesity,
dyslipidemia
dysbiosis
mice
fed
high-fat
diet
(HFD).
After
12
weeks
LPH
treatment,
gained
less
weight
showed
decreased
dysfunction
compared
HFD-fed
group.
HFD-induced
(increased
triglycerides,
cholesterol
LDL
concentration)
were
both
counteracted
by
consumption.
Discriminant
analysis
differentially
distributed
LPH-treated
non-treated
mice.
HFD
reduced
ecological
parameters,
promoted
blooming
deleterious
taxa
abundance
commensal
members.
Some
these
changes
corrected
Finally,
correlation
suggested
that
microbial
population
could
be
responsible
for
improvement
conclusion,
first
show
effect
improving
gain,
adiposopathy
context
diet-induced
pointing
therapeutic
potential
peptides
diseases.
Frontiers in Endocrinology,
Journal Year:
2023,
Volume and Issue:
14
Published: Oct. 11, 2023
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
a
multifactorial
disease.
As
clinical
empirical
prescription
of
traditional
Chinese
medicine,
Qushi
Huayu
decoction
(QHD)
has
attracted
considerable
attention
for
its
advantages
in
multi-target
treatment
NAFLD.
However,
the
intervention
mechanism
QHD
on
abnormal
lipid
levels
and
gut
microbiota
NAFLD
not
been
reported.Therefore,
we
verified
therapeutic
effect
high-fat
diet
(HFD)-induced
rats
by
physiological
parameters
histopathological
examination.
In
addition,
studies
serum
lipidomics
based
16S
rRNA
sequencing
ultra-high
performance
liquid
chromatography-mass
spectrometry
(UPLC-MS)
were
conducted
to
elucidate
QHD.The
changes
are
mainly
reflected
their
diversity
composition,
while
treated
restored
these
changes.
The
genera
Blautia,
Lactobacillus,
Allobaculum,
Lachnoclostridium
Bacteroides
predominant
group,
whereas,
Turicibacter,
Sporosarcina,
Romboutsia,
Clostridium_sensu_stricto_1,
Psychrobacter
NAFLD+QHD
group.
Lipid
subclasses,
including
diacylglycerol
(DG),
triglycerides
(TG),
phosphatidylethanolamine
(PE),
phosphatidylcholine
(PC),
phosphatidic
acid
(PA),
phosphatidylserine
(PS),
lysophosphatidylinositol
(LPI),
phosphatidylglycerol
(PG),
significantly
different
between
control
groups,
altered
DG,
TG,
PA,
lysophosphatidylcholine
(LPC),
lysophosphatidylethanolamine
(LPE),
platelet
activating
factor
(PAF).
Finally,
Spearman's
correlation
analysis
showed
that
related
differential
molecules
associated
with
Bacteroides,
Lachnoclostridium,
which
also
correlated
biological
NAFLD.Taken
together,
may
exert
beneficial
effects
regulating
thus
intervening
lipids.
Food & Function,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 19, 2024
P.
acidilactici
Y01
has
the
anti-obesity
effect
possibly
via
altering
gut
microbiota
and
metabolomic
profiles
modulating
adipose
tissue
macrophage
M1/M2
polarization.
mSystems,
Journal Year:
2023,
Volume and Issue:
9(1)
Published: Dec. 19, 2023
Drug
addiction
can
seriously
damage
human
physical
and
mental
health,
while
detoxification
is
a
long
difficult
process.
Although
studies
have
reported
changes
in
the
oral
microbiome
of
methamphetamine
(METH)
users,
role
that
plays
process
drug
still
unknown.
This
study
aims
to
explore
function
based
on
analysis
variations
metabolome
METH
users.
We
performed
16S
rRNA
sequencing
saliva
samples
collected
from
278
users
105
healthy
controls
(CTL).
In
addition,
untargeted
metabolomic
profiling
was
conducted
220
samples.
Compared
CTL
group,
alpha
diversity
reduced
group
relative
abundances
Food Science & Nutrition,
Journal Year:
2023,
Volume and Issue:
11(10), P. 6686 - 6697
Published: Aug. 24, 2023
Vitamin
D-regulating
action
of
PPARγ
on
obesity
has
been
confirmed
adipocyte
differentiation.
However,
it
is
not
clear
whether
vitamin
D
affects
the
morphological
size
mature
adipocytes
by
influencing
expression
in
vivo.
Our
hypothesis
was
that
D3
(VitD3)
inhibits
growth
suppressing
white
obese
mice.
Five-week-old
male
C57BL/6J
mice
were
randomly
divided
into
normal
diet
and
high-fat
groups.
After
10
weeks,
body
weight
between
two
groups
differed
26.91%.
The
a
diet,
solvent
control,
low-dose
VitD3
(5000
IU/kg·food),
medium-dose
(7500
high-dose
(10,000
PPAR
γ
antagonist
group,
intervention
lasted
for
8
weeks.
Diet-induced
(DIO)
fed
exacerbated
markers
adiposity
(body
weight,
fat
mass,
mass
rate,
brown
adipocytes,
mRNA,
protein
levels
ATGL
Fsp27),
level
Fsp27
decreased
group.
In
conclusion,
possibly
via
inhibiting
expression,
thereby
lipolysis,
increasing
volume
decreasing
their
fat-storing
ability
resulted
expression.
Therefore,
long-term
oral
may
necessarily
improve
obesity,
we
need
more
clinical
trials
to
explore
dose
duration
treatment
deficiency
patients.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 19, 2024
Evidence
is
insufficient
to
establish
a
longitudinal
association
between
combined
trajectories
of
body
mass
index
(BMI)
and
waist
circumference
(WC)
dyslipidemia.
Our
study
aimed
explore
the
multi-trajectories
BMI
WC
incident
dyslipidemia
identify
microbiota
metabolite
signatures
these
trajectories.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: May 7, 2024
Abstract
Obesity
is
a
multifaceted
health
concern
that
impacted
by
genetic,
environmental,
and
behavioral
factors,
with
varying
levels
of
individual
susceptibility.
Research
has
identified
distinct
physiological
characteristics
among
individuals
differing
susceptibilities
to
obesity.
Prior
research
demonstrated
notable
variances
in
gut
microbiota
metabolites
between
obesity-prone
(OP)
those
obesity-resistance
(OR).
However,
the
potential
impact
these
differences
on
serum
remains
uncertain,
as
does
role
metabolite
changes
influencing
susceptibility
We
performed
non-targeted
metabolomic
analysis
samples
from
OP
OR
mice.
Subsequently,
correlation
was
conducted
data
pertaining
metabolites,
microbiota,
obesity-related
indicators,
other
factors.
This
study
aimed
investigate
association
alterations
mice,
well
examine
Our
demonstrates
following
HFD,
8Z,11Z,14Z-Eicosatrienoic
acid
(ESA)
Eicosapentaenoic
(EPA)
can
lipid
through
regulation
Arachidonic
(AA)
EPA.
EPA
also
influences
abundance
Lachnospiraceae_NK4A136_group,
resulting
increased
accumulation.
Moreover,
Ruminiclostridium_9
exacerbates
saturated
fatty
acids
AA
decreasing
Additionally,
Hydroxybenzoic
accumulation
elevating
Choline
levels.
These
contribute
development
obesity,
indicating
variations
play
significant
disparities,
being
influenced
metabolites.